History_CGeneTech (Suzhou, China) Co., Ltd._small molecular innovative drugs

About Us

History

2021 - 2022

beholding the sun blazing forth from a cloudy sky

◆ Shenggliptin, a new hypoglycemic drug, completed Phase III clinical trials ◆ The first domestically produced rare disease drug approved for launch ◆ Four new anti-tumor drugs have been approved for clinical use, and two Sino US dual reports ◆ Awarded as a major innovation team in Suzhou

11month 13day 2023

2020 - 2021

Milestones

◆ Submitting the application for approval of the first generic drug for rare diseases. ◆ The new hypoglycemic drugentering Phase III clinical trials with exemption from Phase II clinical trials. ◆ Jiangsu CGenePharmaceuticalCo Ltd was established.

03month 09day 2021

2019 - 2020

◆ Completing thebioequivalency evaluationof the first generic drug for rare diseases. ◆ Completing Phase I clinical trial of a new hypoglycemic drug. ◆ Raising 150 million yuaninSeries A+ round financing.

03month 09day 2020

2018 - 2019

◆ Raising nearly 100 million yuan in Series A round financing. ◆ Launching clinical trials of a Class 1.1 new hypoglycemic drug. ◆ Receiving funding from the national major special fund during the13th Five-Year period.

03month 09day 2019

2016 - 2018

◆ Successfully obtaininginvestmentin SeriesPre-A round financing. ◆ Obtaining permissions forclinical trials of severalClass3.1 new drugs. ◆ Submitting applications for clinical study of a Class 1.1 new hypoglycemic drug.

03month 09day 2018

2015 - 2016

◆ Winning support from the national major special fund duringthe12th Five-Year period for the project initialization of a Class 1 new drug, and the project was completed without any defects. ◆ Submittingapplications for clinical trials of severalClass3.1 new drugs.

03month 09day 2016

2013 - 2015

Winning the following titles:

◆ InnovativeandEntrepreneurialTalent of Jiangsu Province. ◆ State-levelleading talent.

03month 09day 2015

2012 - 2013

◆ Projectinitialized with support from Jiangsu Province Science and Technology Support Program. ◆ Flash-release preparation engineering technology center was established. ◆ Obtaining venture capital from angel investor.

03month 09day 2013

2010 - 2012

Winning the titles of

◆ Leading Talent of Suzhou Industrial Park. ◆ Leading Innovative and Entrepreneurial Talent of Suzhou.

03month 09day 2012

Key achievements

Science and technology projects

◆ “Major New Drug Creation” program under China’s13th Five-Year Plan
◆ “Major New Drug Creation” program under China’s 12th Five-Year Plan
◆ Project under Jiangsu Province Science and Technology Support Program

Qualifications

◆ Being included in the NurseryforCompany Listing
◆ Private Technology Enterprise
◆ Technology-based SME
◆ SuzhouMunicipal Engineering Technology R&D Center

Industry Leader

◆ State-levelleading talent
◆ Innovative and Entrepreneurial Talent of Jiangsu Province
◆ Leading Innovative and Entrepreneurial Talent of Suzhou
◆ Leading Talent of Suzhou Industrial Park

Achievements

◆ Accumulatively raising nearly 600 million yuan
◆ New hypoglycemic drug entering Phase III clinical trials with exemption from Phase II clinical trials
◆ The first generic drug for rare diseases has been approved to be released to the market
◆ Six IND approvals and 18 granted invention patents